Real-time enrollment status for this ovarian neoplasms clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:56 PM UTC
| NCT Number | NCT06566716 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 1,000 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Cleo Diagnostics Ltd |
| Last Updated on CT.gov | February 4, 2025 (Feb 4, 2025) |
As of August 28, 2026: Clinical trial NCT06566716 is currently recruiting participants. This clinical trial study for ovarian neoplasms is actively seeking new participants at 8 locations across the United States. The study is sponsored by Cleo Diagnostics Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06566716 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06566716 was last updated Feb 4, 2025 (February 4, 2025). HelloStudys verifies this status automatically.